Metformin vs NMN
Head-to-head comparison of Metformin (Metformin Hydrochloride) and NMN (Nicotinamide Mononucleotide) — benefits, dosing, side effects, research data, and where to buy.
| Property | Metformin | NMN |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| Full Name | Metformin Hydrochloride | Nicotinamide Mononucleotide |
| Molecular Weight | 165.63 Da | 334.22 Da |
| Half-Life | 4-8.7 hours | N/A |
| Amino Acids | N/A | N/A |
| Typical Dose | 500-2000 mg/day | 250-1000 mg/day |
| Route | Oral | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 4000 | 300 |
| Research Status | Clinical | Clinical |
Metformin Benefits
- ✓AMPK activation
- ✓improved insulin sensitivity
- ✓reduced oxidative stress
- ✓population-level longevity signal
NMN Benefits
- ✓NAD+ support
- ✓mitochondrial function
- ✓DNA repair support
- ✓metabolic resilience
Metformin Dosing
500-2000 mg/day oral|start low and titrate in trials|taken with meals
NMN Dosing
250-1000 mg/day oral|single or divided doses|daily supplementation in studies
Metformin Side Effects
- ⚠gastrointestinal upset
- ⚠vitamin B12 reduction
- ⚠diarrhea
- ⚠rare lactic acidosis
NMN Side Effects
- ⚠nausea
- ⚠headache
- ⚠GI discomfort
- ⚠flushing
Research Overview
Metformin
Metformin has extensive human data and remains a leading candidate in geroscience research. Observational and mechanistic studies suggest it may influence pathways tied to aging, though definitive anti-longevity proof in healthy humans is still lacking.
NMN
NMN has a substantial preclinical and growing human literature centered on raising NAD+ levels. Research is strongest for biomarker changes and metabolic endpoints, while long-term aging outcomes remain under investigation.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.